UMedic Group Bhd (UMC.KL) Stock Price

UMedic Group Bhd Price

CLOSED
0.29
​
Market closed

Revenue has compounded at 16.3% per year over the past 6 years to 58.69 M MYR. Earnings per share have grown at 21.3% per year over the last 6 years. UMedic Group Bhd's net margin stands at 13.1%, broadly stable from 12.7% several years earlier. UMedic Group Bhd currently offers a dividend yield of about 1.05%. Analysts set a median price target of 0.34 MYR, implying 19.9% above the current price. Of 8 analysts, 0 rate the stock a buy — an overall Sell consensus.

UMedic Group Bhd stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

UMedic Group Bhd business model & stock analysis

UMedic Group Bhd.is an investment holding company, which engages in the marketing and distribution of medical devices and consumables through its subsidiaries. The company is headquartered in Penang, Pulau Pinang. The company went IPO on 2022-07-26. The firm operates through two segments: Marketing and distribution and Manufacturing. Marketing and distribution segment is engaged in the marketing and distribution of medical devices as well as the provision of after sales service. Manufacturing segment is engaged in the developing, manufacturing and marketing of medical consumables, namely HydroX series prefilled humidifiers and AirdroX series inhaler spacers. The Company, through its subsidiaries, is principally involved in marketing, distribution, and manufacturing of medical devices as well as the provision of aftersales service. Its products include Hospital Furniture, Life-Support Solution, MR Compatible Monitoring Solution, Oxygen Therapy & Suction Solution, Patient Monitoring System, Resuscitation Care, Ultrasound Solution, Women & Child Care, Anesthesia Solution. Its services include clinical training on equipment, equipment pre-checks, and others.

Frequently asked questions about UMedic Group Bhd

Analysts currently set an average price target of 0.34 MYR for the UMedic Group Bhd stock (median: 0.34 MYR), implying +19.9 % versus the latest price. The consensus is based on 8 analyst ratings.

8 analysts currently rate the UMedic Group Bhd stock: 0 recommend buying, 4 holding and 4 selling.

Converted at the current exchange rate, the UMedic Group Bhd share trades at 0.06 EUR (0.29 MYR).

The revenue of UMedic Group Bhd is 58.69 M MYR. This figure is based on current financial data and reflects the company's business performance.

The profit of UMedic Group Bhd is 7.72 M MYR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of UMedic Group Bhd is currently 13.81. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the UMedic Group Bhd stock.

The price-to-sales ratio (P/S) of UMedic Group Bhd is currently 1.82. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the UMedic Group Bhd stock.

The Eulerpool Quality Score for UMedic Group Bhd is 4/10.

The ISIN of UMedic Group Bhd is MYQ0256OO006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of UMedic Group Bhd is UMC.KL. The ticker symbol is used to trade UMedic Group Bhd shares on the stock exchange.

Fair ValueTerminal
0.24 MYR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Malaysia
Currency
MYR
Initial public offering
Jul 26, 2022
ISIN
MYQ0256OO006
Cusip
Y9045L104
Market capitalization
106.56 M MYRMicro Cap
52-Week Range
PEG
4.91
P/E ratio
P/Ee 2027
12.03
P/Ee 2028
11.26
P/Ee 2028
11.07
P/S
P/Se
1.75
EV/EBIT
11.25
P/B Ratio
1.23
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
8.58 %
Last updated Oct 16, 2026, 1:16 PM

UMedic Group Bhd Peer Group

UMedic Group Bhd FIGI

UMC:MK · BBG018NCXKM4